DETTI, BEATRICE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.660
AS - Asia 1.647
EU - Europa 1.178
SA - Sud America 150
AF - Africa 41
OC - Oceania 25
Totale 4.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.616
RU - Federazione Russa 548
CN - Cina 536
SG - Singapore 464
IT - Italia 236
HK - Hong Kong 216
KR - Corea 167
BR - Brasile 117
VN - Vietnam 107
IE - Irlanda 82
FR - Francia 77
DE - Germania 68
FI - Finlandia 44
SE - Svezia 44
IN - India 42
GB - Regno Unito 28
CA - Canada 26
JO - Giordania 26
AU - Australia 24
ID - Indonesia 18
BD - Bangladesh 12
NL - Olanda 11
AR - Argentina 10
TR - Turchia 10
IQ - Iraq 9
JP - Giappone 8
NG - Nigeria 8
ES - Italia 7
PL - Polonia 7
ZA - Sudafrica 6
EC - Ecuador 5
SA - Arabia Saudita 5
TN - Tunisia 5
UY - Uruguay 5
CL - Cile 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LY - Libia 4
MA - Marocco 4
MX - Messico 4
UA - Ucraina 4
BY - Bielorussia 3
CI - Costa d'Avorio 3
GR - Grecia 3
LT - Lituania 3
PH - Filippine 3
PY - Paraguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CO - Colombia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
VE - Venezuela 2
AO - Angola 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
GD - Grenada 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
IR - Iran 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TJ - Tagikistan 1
TL - Timor Orientale 1
VC - Saint Vincent e Grenadine 1
Totale 4.701
Salva come PNG Salva come JPEG
Città #
Santa Clara 535
Singapore 363
Ashburn 278
Hefei 222
Hong Kong 192
Seoul 167
San Jose 109
Dublin 81
Chandler 80
Munich 50
Beijing 46
Los Angeles 46
Milan 43
New York 38
Ho Chi Minh City 31
Paris 30
Kent 29
Lauterbourg 27
Buffalo 24
Moscow 23
Melbourne 22
Florence 20
Hanoi 20
Turku 19
São Paulo 17
The Dalles 17
Helsinki 16
Shanghai 16
West Jordan 15
Bengaluru 14
Rome 14
Dallas 13
Chicago 12
Jakarta 12
Boston 10
Montreal 10
Orem 10
Frankfurt am Main 9
Lappeenranta 9
London 9
Naples 9
Mumbai 8
Abuja 7
Council Bluffs 7
Altamura 6
Brooklyn 6
Cascina 6
Da Nang 6
Lawrence 6
Seattle 6
Tokyo 6
Warsaw 6
Atlanta 5
Baghdad 5
Guangzhou 5
Haiphong 5
Pune 5
Stockholm 5
Tampa 5
Toronto 5
Wilmington 5
Yubileyny 5
Biên Hòa 4
Boardman 4
Bologna 4
Brescia 4
Fairfield 4
Johannesburg 4
Lucca 4
Palermo 4
Princeton 4
Southwark 4
Thái Bình 4
Tripoli 4
Abidjan 3
Anacortes 3
Belo Horizonte 3
Chennai 3
Dagenham 3
Garden City 3
Houston 3
Maldonado 3
New Delhi 3
Newark 3
Ninh Bình 3
Phoenix 3
Pontedera 3
Porto Alegre 3
San Diego 3
San Francisco 3
Skikda 3
Tashkent 3
Tunis 3
Turin 3
Wuhan 3
Almaty 2
Ankara 2
Bishkek 2
Buenos Aires 2
Cambridge 2
Totale 2.948
Salva come PNG Salva come JPEG
Nome #
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 195
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients 188
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 186
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials 184
Pleomorphic Xanthoastrocytoma: a single institution retrospective analysis and a review of the literature 177
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 176
Regorafenib in glioblastoma recurrence: A case report 176
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 172
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 168
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 166
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 165
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 164
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 164
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 163
Radiotherapy for elderly patients with glioblastoma: an assessment of hypofractionation and modern treatment techniques 163
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 161
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 160
Local treatment for relapsing glioblastoma: A decision-making tree for choosing between reirradiation and second surgery 157
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 153
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients 145
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 144
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 144
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 142
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 139
Antiangiogenic drugs as chemosensitizer in genitourinary cancer 138
Synchronous bilateral testicular germ cell tumour: Case report and review of the literature 133
Dose-escalated pelvic radiotherapy for prostate cancer in definitive or postoperative setting 126
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 118
Antiangiogenic drugs as chemosensitizer in renal cell cancer 115
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 112
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes 28
Totale 4.722
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202239 0 0 0 15 3 0 0 4 1 1 6 9
2022/2023330 10 27 8 18 35 80 53 25 60 1 5 8
2023/2024273 11 19 26 21 14 43 17 67 2 22 18 13
2024/20251.819 43 142 92 252 445 245 28 125 88 79 107 173
2025/20262.261 271 352 352 231 206 59 244 98 108 115 86 139
Totale 4.722